Biocon group net up 51 percent in fiscal 2013

Bangalore, April 26 (IANS) India's biotechnology major Biocon Ltd posted consolidated net profit of Rs.509 crore for fiscal 2012-13, registering a whopping 51 percent year-on-year (YoY) growth over previous fiscal (2011-12) at Rs.338 crore.

In a regulatory filing to the Bombay Stock Exchange (BSE) Friday, the Bangalore-based firm said consolidated income for the fiscal (FY 2013) under review grew 18 percent YoY to Rs.2,538 crore from Rs.2,148 crore year ago.

On standalone basis, the parent company, however, reported a modest eight percent YoY net profit growth of Rs.276 crore from Rs.256 crore year ago and income of Rs.1,989 crore for last fiscal, which is 23 percent up YoY from Rs.1,622 crore year ago.

"Fiscal 2013 closed on a very strong note, with growth driven by research services, branded formulations and bisimilar services, led by generic insulins," Biocon chairperson Kiran Mazumdar Shaw told reporters.

Biopharama business grew 10 percent YoY to Rs.1,523 crore, while branded formulations 34 percent YoY to 347 crore and research services (Syngene & Clinigene) 36 percent YoY to Rs.557 crore.

"Our insulin franchise continues to garner market share across India and emerging markets and accounts for 10 percent of our sales," Shaw said.

The company extended partenership with the US-based specialty pharma firm Mylan by re-licensing its generic insulins and thereby reducing development costs involved in global commercialisation.

"Looking ahead, we intend to sustain the growth momentum by optimising small molecules portfolio, expanding insulin footprint in emerging markets and continuing to deliver robust growth in branded formulations and research services," Shaw asserted.

The company received $200 million (Rs.1,100 crore) from Mylan as an upfront for further development of generic insulins.

For fourth quarter (January-March), total revenue grew only four percent YoY to Rs.649 crore from Rs.622 crore year ago, but declined two percent sequentially from Rs.660 crore posted in October-December of fiscal under review.

Net profit for fourth quarter (Q4), however, shot up 170 percent sequentially to Rs.249 crore from Rs.92 crore in third quarter (Q3) and 154 percent YoY from Rs.98 crore in like quarter year ago.

Though operating margin or earnings before interest, depreciation and amortization (Ebitda) increased three percent YoY to Rs.596 crore from Rs.578 crore year ago, it declined sequentially 26 percent to Rs.124 crore in fourth quarter (Q4) from Rs.167 crore in third quarter (Q3) and 21 percent YoY from Rs.156 crore in same quarter year ago.

The company's board of directors recommended 100 percent dividend of Rs.5 per share and 50 percent special dividend of Rs.2.50 per share in pursuant to the re-licensing of its insulin analogs portfolio.

Matches

MORE TOP STORIES TODAY

Bangalore's arsenal blazes to victory

Bangalore's arsenal blazes to victory

Yuvraj Singh was back to his best in his first match for Royal Challengers Bangalore. More »

Time for Chennai to enter familiar cocoon

Time for Chennai to enter familiar cocoon

Chennai have been able to purchase batting replacements for the loss of Michael Hussey and spin reinforcements in the form of Samuel Badree. They appear… More »

Evenly matched Rajasthan and Hyderabad face-off

Evenly matched Rajasthan and Hyderabad face-off

A quality that defines Rajasthan and Hyderabad is consistency. Rajasthan was one among two teams to enjoy complete dominance at home last season. Hyderabad… More »

BCCI to meet before next court hearing

BCCI to meet before next court hearing

The BCCI will hold an emergent working committee meeting on April 20 to discuss the future course of action with regard to the Supreme Court hearing concerning… More »

Kallis, Narine star in Knight Riders’ crushing win

Kallis, Narine star in Knight Riders’ crushing win

An all-round display saw Knight Riders thump Mumbai Indians by 41 runs in the IPL-7 opener. More »

Gavaskar wants a clean IPL

Gavaskar wants a clean IPL

"Integrity is non-negotiable..." says the BCCI's interim chief ahead of Season 7 of the tainted league. More »

'Yak' Kallis still on top of his game

'Yak' Kallis still on top of his game

The 38-year-old South African veteran turned it on for Kolkata Knight RIders in the opening match of IPL-7. More »

Srinivasan named in fixing report: SC

Srinivasan named in fixing report: SC

The court emphasised that the tainted administrator can no longer work for the BCCI. More »

Yuvraj happy to play for RCB: Kohli

Yuvraj happy to play for RCB: Kohli

New-look RCB will play their first game of IPL-7 on Thursday. More »

Shane Watson issues moral warning

Shane Watson issues moral warning

'Everyone knows what is right and what is wrong and if you do the wrong thing it will be found out' More »

Why I'm not looking forward to the IPL

Why I'm not looking forward to the IPL

Welcome to another season of a league that many watch but few trust. More »

IPL: News Line

IPL: News Line

A round-up of all the news from this season of the IPL. More »

Johnson may quit T20s for Tests

Johnson may quit T20s for Tests

Australia's Mitchell Johnson may quit limited-overs cricket to prolong his test career with an eye on the 2015 Ashes series in England, the fast bowler… More »

Nepal players call off boycott

Nepal players call off boycott

Thaw in relations after formation of an advisory committee that would work in tandem with the Cricket Association of Nepal. More »

There's a lot going on: Fleming

There's a lot going on: Fleming

He experienced anxious moments in the lead-up to the tournament as the courts decided on whether to suspend the franchise, he said, but stressed that the… More »

Latif couldn’t work with tainted players

Latif couldn’t work with tainted players

Former Pakistan cricket captain Rashid Latif said Tuesday he turned down the job of national chief selector because he could not work with ex-players tainted… More »

We are not over-confident: Bailey

We are not over-confident: Bailey

Indian Premier League — George Bailey-led Kings XI Punjab will face Chennai Super Kings on Friday. More »

Big runs expected, with bat and ball

Big runs expected, with bat and ball

Royal Challengers Bangalore: Their main concern, once again, is the fast bowling More »

Taxing issue — BCCI hits roadblock

Taxing issue — BCCI hits roadblock

MoU between BCCI & its units to avoid double taxation delayed after a few decline to share details. More »

Black Caps pick rookie duo for West Indies

Black Caps pick rookie duo for West Indies

New Zealand selectors included two new caps in a 15-man Test squad named Tuesday to tour the West Indies, with injury-hit spinner Dan Vettori's future… More »

The stage is set for IPL-7 to start

The stage is set for IPL-7 to start

The Preview — Defending champions Mumbai Indians take on Kolkata Knight Riders More »

Srinivasan appeals to court to allow BCCI comeback

Srinivasan appeals to court to allow BCCI comeback

He was aggrieved by the allegations against him during the hearing. More »

India: cricket's Brazil

India: cricket's Brazil

They are tough to beat with a big talent base exposed to good facilities. (CYCSPL) More »

Delhi Daredevils say no to gifts

Delhi Daredevils say no to gifts

Franchises are doing their bit to refurbish the image of the tainted league. More »